No Data
No Data
Galera Therapeutics | 10-K: FY2024 Annual Report
Galera Therapeutics Insider Bought Shares Worth $499,979, According to a Recent SEC Filing
Express News | Galera Therapeutics Completes Acquisition of Nova Pharmaceuticals
Press Release: Galera Therapeutics Completes Acquisition of Nova Pharmaceuticals
Galera Therapeutics | 10-Q: Q3 2024 Earnings Report
Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition Corp.; AERWINS...